Testosterone and cardiovascular risk in men

Daniel M Kelly1, T Hugh Jones

  • 1Department of Human Metabolism, Medical School, The University of Sheffield, Sheffield, UK.

Insights

Testosterone deficiency is common in men with cardiovascular disease (CVD) and linked to higher mortality. Optimizing testosterone levels may improve cardiovascular health, but careful monitoring is crucial to avoid risks.

Area of Science:

  • Endocrinology
  • Cardiology
  • Men's Health

Background:

  • Testosterone deficiency is prevalent in men with cardiovascular disease (CVD), correlating with increased mortality.
  • Low testosterone negatively impacts cardiovascular risk factors like insulin resistance, diabetes, dyslipidemia, central obesity, and endothelial dysfunction.
  • The role of testosterone deficiency in atherogenesis versus being a biomarker of poor health is debated.

Purpose of the Study:

  • To investigate the relationship between testosterone levels and cardiovascular disease (CVD) outcomes.
  • To evaluate the impact of testosterone replacement therapy (TRT) on cardiovascular risk factors and mortality in hypogonadal men.
  • To determine the optimal testosterone level for cardiovascular health and the risks associated with undertreatment or overtreatment.

Main Methods:

  • Review of animal studies, cell experiments, and epidemiological data on testosterone and cardiovascular health.
  • Analysis of studies on testosterone replacement in hypogonadal men, examining effects on risk factors, exercise capacity, and mortality.
  • Comparison of cardiovascular events and mortality across different endogenous testosterone level ranges.

Main Results:

  • Animal and cell studies suggest testosterone beneficially modulates atherosclerotic mechanisms.
  • Epidemiological data indicate reduced cardiovascular events and mortality in men with mid-to-upper normal testosterone levels.
  • TRT achieving mid-normal levels shows benefits for cardiovascular risk factors, ischemia, exercise capacity, and mortality; however, undertreatment or high-dose TRT is linked to increased cardiovascular events.

Conclusions:

  • Testosterone plays a role in cardiovascular health, with mid-normal levels associated with better outcomes.
  • Testosterone replacement therapy can be beneficial for hypogonadal men, improving cardiovascular risk factors and mortality.
  • Precise clinical monitoring and dose titration of testosterone are essential to maximize benefits and minimize cardiovascular risks.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
756
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.3K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
751